epiK™ is specifically designed to overcome traditional hurdles of drug discovery and development by leveraging the following advantages:
- Therapeutic category agnostic, small molecule drug discovery platform that dramatically accelerates research and development timelines while generating compounds with increased probability of success.
- Robust intellectual property portfolio protecting technology and molecules.
- Strategic investment through early, data-rich decision making which facilitates early attrition of sub-optimal targets and drug leads.
- Scalable, robust, flexible discovery engine that leverages ultra high throughput screening and compound profiling capabilities to generate and analyze multidimensional data, resulting in the selection of high quality drug leads.
- Saturation Discovery enables the rapid interrogation and validation of new targets, and continual replenishment of pipelines.
- Data-rich interrogation of targets and compounds, enabling multiple potential therapeutic uses for each product candidate.
- Provides novel and clearly differentiated clinical compound profile for a given target relative to the competition.